MEAN NUCLEAR VOLUME OF BLADDER-CANCER - STEREOLOGICAL ESTIMATION AND ITS CLINICAL-VALUE

被引：2

作者：

ARIMA, K

SUGIMURA, Y

TOCHIGI, H

KAWAMURA, J

机构：

[1] Department of Urology, Mie University School of Medicine, Tsu, Mie

来源：

UROLOGIA INTERNATIONALIS | 1993年 / 51卷 / 02期

关键词：

MEAN NUCLEAR VOLUME; STEREOLOGY; BLADDER CANCER; PROGNOSIS; BALLOON-OCCLUDED ARTERIAL INFUSION;

D O I：

10.1159/000282515

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Mean nuclear volumes (MNVs) of bladder cancer cells from the specimens of 100 patients were estimated by stereological procedure. The value of MNVs of bladder cancer were ranged widely, from 114.6 to 1,041.9 mum3. However, strong correlation was observed between MNV and histopathological grade and stage. Furthermore, the MNV predicts the biological behavior including the malignant potential and prognosis of the patient. Patients with MNV below 315 mum3 had significantly better prognosis than those with MNV above this value (p < 0.01). The 5- and 10-year survival rates for patients with MNV below 315 mum3 were both 97%, while those for patients with MNV above 315 mum3 were 65 and 58%, respectively. MNVs of the recurrent tumors were significantly increased, compared with those of the initial tumors (p < 0.01). MNV of extirpated tumor specimens following chemotherapy consisting of cisplatin and Adriamycin through balloon-occluded arterial infusion (BOAI) was significantly decreased, compared with that before BOAI (p < 0.01). We conclude that the MNV is an excellent predictor for the prognosis of the patient and the tumor recurrence. Furthermore, the stereological estimation of nuclear volume is a simple, quick, inexpensive, and reliable method to assess quantitative analysis of the histological and biological character of bladder cancer.

引用

页码：62 / 66

页数：5

共 20 条

[11]

Orntoft T.F., Nielsen K., Heterogeneic expression of blood group A and H isoantigens in bladder tumors: Association with nuclear volume, J Histochem Cytochem, 37, pp. 1153-1155, (1989)

[12]

Langkilde N., Wolf H., Clausen H., Kjeldsen T., Orntoft T.F., Nuclear volume and expression of T-antigen, sialosyl-Tn-antigen, and Tn-antigen in carcinoma of the human bladder, Cancer, 69, pp. 219-227, (1992)

[13]

Yamada T., Fukui L., Yokokawa M., Oshima H., Changing expression of ABH blood group and cryptic T-antigens of non invasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression, Cancer, 61, pp. 721-726, (1988)

[14]

Coon J.S., Weinstein R.S., Summers J.L., Blood group precursor T-antigen in human urinary bladder carcinoma, Am J Clin Pathol, (1982)

[15]

Summers J.L., Coon J.S., Ward R.M., Falor W.H., Miller A.W., Weinstein R.S., Prognosis in arcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumor, Cancer Res, 43, pp. 934-939, (1983)

[16]

Orntoft T.F., Wolf H., Watkins W.M., Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium, Cancer Res, 48, (1988)

[17]

Sasaki M., Kaneko Y., Stereological estimation of mean nuclear volume in bladder cancer - Measurement by point-sampled intercepts, Acta Urol Jpn, 36, pp. 909-913, (1990)

[18]

Fukuzawa S., Hashimura T., Horii Y., Yoshida O., Sasaki M., Yamabe H., Clinical significance of the stereological estimation of mean nuclear volume in human bladder carcinoma, Acta Urol Jpn, 38, pp. 25-29, (1992)

[19]

Nielsen K., Orntoft T., Wolf H., Stereologic estimates of nuclear volume in noninvasive bladder tumors (T<sub>a</sub>) correlated with the recurrence pattern, Cancer, 64, pp. 2269-2274, (1989)

[20]

Hori N., Hayashi N., Kinoshita N., Hoshina A., Tochigi H., Kawamura J., Toyoda S., The clinicopathological study of bladder tumor. 2. The effect of balloon-occluded arterial infusion method, Jpn J Urol, 78, pp. 2011-2015, (1987)

← 1 2 →